Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium

MLA

Dae Won Jun, et al. “Direct-Acting Antivirals in East Asian Hepatitis C Patients: Real-World Experience from the REAL-C Consortium.” Hepatology International, vol. 13, Aug. 2019, pp. 587–98. EBSCOhost, https://doi.org/10.1007/s12072-019-09974-z.

APA

Dae Won Jun, Gin-Ho Lo, Chung-Feng Huang, Hiroaki Haga, Cheng-Hao Tseng, Yuichiro Eguchi, Satoshi Yasuda, Ming-Lung Yu, Yasuhito Tanaka, Leslie Y. Kam, Akihiro Tamori, Jae Yoon Jeong, Etsuko Iio, Jee-Fu Huang, Mindie H. Nguyen, Chi-Ming Tai, Dong Hyun Lee, Hwai I. Yang, Mei Hsuan Lee, … Toshifumi Tada. (2019). Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatology International, 13, 587–598. https://doi.org/10.1007/s12072-019-09974-z

Chicago

Dae Won Jun, Gin-Ho Lo, Chung-Feng Huang, Hiroaki Haga, Cheng-Hao Tseng, Yuichiro Eguchi, Satoshi Yasuda, et al. 2019. “Direct-Acting Antivirals in East Asian Hepatitis C Patients: Real-World Experience from the REAL-C Consortium.” Hepatology International 13 (August): 587–98. doi:10.1007/s12072-019-09974-z.